Novartis India LtdPharmaceuticalsINE234A01025Standalone₹2057.50-23.35 (-1.12%)Jun-26
Valuation
Market Cap₹5.08K Cr
TTM PE51.94x
Forward PE51.78x
PEG1.06
Book Value₹317.92
P/B6.47x
TTM EPS₹39.61
Fwd EPS₹39.73
TTM Revenue₹370.59 Cr
TTM PAT₹97.77 Cr
TTM EBITDA₹101.77 Cr
TTM EBIT₹99.93 Cr
Last Qtr PAT₹32.21 Cr
Last Qtr EBITDA₹34.91 Cr
Last Qtr EBIT₹34.49 Cr
Profitability
ROE12.46%
ROCE17.00%
TTM NPM26.38%
TTM EBITDA %27.46%
Curr OPM31.03%
Last OPM27.89%
Curr NPM—
Last NPM—
Curr EPS₹13.05
Last EPS₹10.23
Balance sheet
Equity₹12.34 Cr
Reserve₹772.62 Cr
Total Debt₹6.03 Cr
D/E0.01x
Interest %0.19%
Curr Interest₹0.06 Cr
Price / range
Close₹2057.50
vs 52W High-20.50%
vs 52W Low+174.33%
MA50—
MA200—
Returns
1D-1.12%
1W-14.03%
1M+29.07%
3M+50.70%
6M+121.52%
1Y+128.53%
2Y+91.90%
3Y+176.23%
5Y+146.02%
Diwali+164.21%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 1 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits